Find a company
Search the SBRI Healthcare and NHS Cancer Programme Innovation Open call portfolio.
If you would like further information on any of the companies listed in the Directory please contact the SBRI Healthcare PMO by email sbri@lgcgroup.com or tel: +44 20 8843 8125.
We would be happy to make introductions to the companies or provide any further feedback you require.
At a glance
Directory search results
Adherium Europe Ltd
| Project | Smart Digital inhaler enabled asthma management in high-risk children aged 5 to 16 years managed in primary care to prevent asthma attacks |
|---|---|
| Description |
Children with asthma often have flare-ups that require hospitalisation. This project will use Hailie® digital inhalers that alert the child and display usage on the family’s smartphone. Via the web, the medical team can monitor and support families and their child’s medication; with the aim to reduce these asthma attacks. |
| Funding | £ 499,871 |
| Competition | Competition 21 - Phase 3, Real-world Implementation: Respiratory Diseases and Cardiovascular Diseases |
| Competition Date | June 2022 |
| Categories | Respiratory |
| Health Innovation Network Partner | Health Innovation East Midlands |
| Website | https://www.adherium.com |
Medisyne
| Project | Automated Urine output monitoring in the Acute setting (AURA study): Supporting the NHS workforce to reduce plastic urometer waste and deliver net zero surgical care |
|---|---|
| Description |
Medisyne Ltd is building an environmentally friendly, reusable, computer-based device that automatically records the amount of urine a patient produces in order to detect complications early. This device will replace the existing disposable, plastic measuring devices that contribute to NHS environmental pollution while freeing nursing staff. |
| Funding | £ 100,000 |
| Competition | Competition 22 - Delivering a net zero NHS: Clinical Innovation Competition |
| Competition Date | July 2022 |
| Categories | Net zero |
| Health Innovation Network Partner | Health Innovation Oxford & Thames Valley |
| Website | https://www.medisyne.co.uk |
AiSentia Ltd
| Project | Next-Generation computerised tomography (CT) imaging using CT Digital Contrast to replace current standard iodinated contrast agent – A feasibility study of clinical and environmental impact |
|---|---|
| Description |
This technology will de-carbonize CT imaging by reducing the levels of iodine in hospital wastewater / the wider environment, the amount of packaging (needle/pump injector plastic tubing, etc.), as well as the supply chain required. All achieved while providing a patient-first approach with seamless integration into current clinical workflows that increases procedure efficiency. |
| Funding | £ 99,420 |
| Competition | Competition 22 - Delivering a net zero NHS: Clinical Innovation Competition |
| Competition Date | July 2022 |
| Categories | Net zero |
| Health Innovation Network Partner | Health Innovation Oxford & Thames Valley |
| Website | https://aisentia.com/ |